Skip navigation
Watchlist Sponsored By :


Current DateTime: 10:30:59 27 Nov 2009
LinksList Documentid: 24355697
  • Runway Angels

      The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.

  • Smartphone Guide

      Here's a need-to-know guide to nine devices, based on features, price, network and platform.

  • Wines for the Holidays

      Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES


Current DateTime: 10:30:59 27 Nov 2009
LinksList Documentid: 33793611
  • How Well Do You Know Your Bird?

      Let's talk turkey. Test your turkey knowledge and perhaps pick up a bit of trivia to trot out at your holiday meal.

  • A Healthier & Wealthier You

      Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.

  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?


Current DateTime: 10:30:59 27 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
Avandia Study Results Were Leaked Early to Glaxo
By: Mike Huckman,, CNBC Pharmaceuticals Reporter | 30 Jan 2008 | 12:46 PM ET
Text Size

The wall between a prestigious medical journal and a major drug company may have been shattered.
GlaxoSmithKline Avandia
Alastair Grant / AP
GlaxoSmithKline headquarters in London.

The scientific journal Nature reported today that a peer-reviewer for The New England Journal of Medicine leaked key study results on GlaxoSmithKline's diabetes drug Avandia to the company weeks before they were published.

Steven Haffner with the University of Texas Health Science Center in San Antonio faxed the study to a Glaxo [GSK  Loading...      ()   ] employee he had worked with on an earlier Avandia study.

Haffner told Nature, "Why I sent it is a mystery. I don't really understand it. I wasn't feeling well. It was bad judgment. I've got a considerable amount of money. I didn't do it to raise my income or anything like that."

Today, Senator Chuck Grassley, the ranking member of the Senate Finance Committee, sent this letter inquiring about the leak to Glaxo's top U.S. executive.

The study in question--an analysis of many clinical trials--showed that Avandia may increase the risk of heart attacks. UK-based Glaxo's stock plummeted when the results were released May 21.

The Food and Drug Administration put a stiff warning on Avandia's label over the findings.

A Glaxo spokesperson told Nature that the inside knowledge that the company had about the study's pending publication "added an additional sense of urgency" to swiftly get the interim results of a more favorable Glaxo-sponsored study published in NEJM.

CNBC's Pharmaceutical Insider:

Peer-reviewers who break confidentiality rules are typically banned from doing future reviews and writing articles or editorials.

The Glaxo employee who received the fax is the senior director of the company's Metabolism Development Center. A Glaxo spokesperson said Haffner sent the study to the employee to get his take on it, but the company told Haffner it couldn't help him.

The spokesperson says the Glaxo executive "didn't do anything wrong."

© 2009 CNBC.com
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • These four sectors will be the next to lead the market.
  • Zhu Zhu Pets are this year's must-have toy, fetching $40 or more on eBay.
  • T shirt man
  • From the why-didn’t-I-think-of-that file, we present Jason Sadler, a man whose job is wearing T-shirts.
  • It may be the most unusual guide to business you'll read.
  • Shopping for a gadget hound? The choices can be baffling. Here are a few that should be a hit.
  • "The Who" will be the halftime act for Super Bowl XLIV on Feb. 7 in Miami. Is the NFL behind the times?
ADD COMMENTS
Remaining characters


Current DateTime: 06:14:06 27 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 09:11:30 27 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 10:38:14 27 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 07:56:29 27 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters